Skip to main content
. 2020 Dec 3;27(1):1073274820977114. doi: 10.1177/1073274820977114

Figure 2.

Figure 2.

Development of a prognostic immune-related risk signature associated with HCC patient outcomes. (A-B) Using LASSO regression analyses, 5 genes associated with HCC patient OS were identified, and 10-round cross-validation was conducted to avoid overfitting. (C) High- and low-risk HCC patient OS was evaluated using Kaplan–Meier curves. (D) Time-dependent ROC analyses of the identified immune-related risk signature in the training cohort.